CASP3 and neoplasm: Integrin αvβ3-binding peptides were however not only used for tumor targeting but also for the design of peptidic heterodimers intended to exert a pro-apoptotic effect on the target cell by caspase-3 activation, whereas the second peptide enables binding to the target tumor cell.